Baylor College of Medicine: Researchers identified markers of chemotherapy resistance and outcome in triple negative breast cancer
August 25, 2022
August 25, 2022
HOUSTON, Texas, Aug. 25 (TNSjou) -- The Baylor College of Medicine issued the following news:
Researchers at Baylor College of Medicine and the Broad Institute of MIT and Harvard and clinicians at Washington University in St. Louis have identified biological markers in triple negative breast cancer (TNBC) that are associated with resistance to chemotherapy treatment. The study is published in the journal Cancer Discovery and was funded by the National Cancer Institute's Clinica . . .
Researchers at Baylor College of Medicine and the Broad Institute of MIT and Harvard and clinicians at Washington University in St. Louis have identified biological markers in triple negative breast cancer (TNBC) that are associated with resistance to chemotherapy treatment. The study is published in the journal Cancer Discovery and was funded by the National Cancer Institute's Clinica . . .